European Pharmaceutical Review’s Post

Just completed an incredible webinar by the International Pharmaceutical Federation (FIP) on the impact of Artificial Intelligence in drug development and clinical trials! So excited to explore how AI is shaping the future of pharmaceuticals. #AI #PharmaceuticalInnovation #DrugDevelopment #FIP #FutureOfMedicine

I had the privilege of attending the recent Society Of Pharmaceutical Sciences and Research (SPSR) 44th International Webinar on "Microsponge as a novel strategy of Drug Delivery System". The webinar was an incredible opportunity to learn about the latest advancements in drug delivery systems. I gained valuable insights into the use of microsponges, which are novel drug delivery systems that can improve the efficacy and safety of drugs. It was great to connect with professionals in the field and learn from their experiences. Overall, the webinar was informative and engaging. #SPSR #DrugDeliverySystem #Microsponge #PharmaceuticalSciences #Webinar

During our meeting with the EC and the sister projects on 10 December in Brussels, we raised following question to our project coordinator Christian Stevens: "How does the project cluster contribute to greening pharmaceutical production in Europe?" His dedicated answer can be found in following video. #TransPharm#sustainability#EU

I am thrilled and highly honoured to have been a part of such an innovative conference and to enrich my knowledge on 'Recent Trends in Pharmaceutical Sciences and Research'. This National Conference has helped me deepen my knowledge and insight about the new innovations of the pharmaceutical world #Pushpagiri_College_of_Pharmacy #Pushpagiri_medical_society #National_Conference #Pharmaceutical_Science #Pharmaceutical_Research

Novel excipients are critical to developing new drug modalities and therapies, but the limited number of novel excipients available creates challenges and limitations to drug development and innovation. Pharmaceutical manufacturers may be reluctant to introduce a novel excipient into a new drug application, as there may be a high level of uncertainty surrounding the potential regulatory acceptance of the excipient. Policies and initiatives to facilitate the introduction and use of novel excipients should rely not only on increased cooperation and coordination between stakeholders but on regulatory developments to support their use in new therapies and modalities. Learn more about the need to address and overcome barriers with novel excipients and USP’s policy position at our Novel Excipients Knowledge Hub ➡️: https://ow.ly/wkGl50REvkj

Delighted to share my participation in the webinar on "Importance of Patient Safety in Global Drug Development." A big thanks to Indian Pharmaceutical Association (IPA), IPA Students' Forum, and ClinoSol Research for organizing this insightful session. #Pharmaceuticals #PatientSafety #DrugDevelopment #IPA #ClinoSol

"Start preparing early" would be my most important advice for building a successful consortium and proposal. At IHI we publish the draft topics openly well ahead of call launch - do make the most of this opportunity! Innovative Health Initiative (IHI) Call 8 promise to be very exciting - piloting new approaches to #HeartDisese, transform #osteoarthritis with big data approaches, #DigitalEndpoints to better understand the patient's experience of disease and an opportunity to work with a large industry consortium to shape Europe's approach to #RegulatorySandboxes:

📣 Innovative Health Initiative (IHI) Call 8 draft topics are published! 📌 "Before anything else, preparation is the key to success" - Alexander Graham Bell. #HeartDisease #Osteoarthritis with big data approaches #DigitalEndpoints to better understand the patient's experience of disease #RegulatorySandboxes

🎙️Tune in to hear PwC specialists discuss strategies to reinvent the pharma business model and drive growth in the pharmaceutical industry.

What's new with SFDA? The U.S. Department of Health and Human Services Food and Drug Administration released guidance for the industry on Container Closure System and Component Changes for Glass Vials and Stoppers in July 2024. This update falls under the Pharmaceutical Quality/Manufacturing Standards set by the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). Stay informed on the latest updates in the industry! #SFDA #FDA #Pharmaceuticals #ManufacturingStandards